I rather suspect that until the 2007 Guideline for Chronic Fatigue Syndrome (with a nod to ME if you like to keep people happy) that there was no clear formal recognition of the existence of the diagnosis relevant to legal issues. Maybe there were chapters in books but a NICE Guideline sort of makes a disease real - and allows people to justify their clinics.
I've highlighted this this morning referening the CMO 2002 United Kingdom: Science Media Centre (including Fiona Fox)
- Here's the parliamentary brief which set up the review Chronic Fatigue Syndrome/ME (parliament.uk) Research briefing 1998
"Summary of main points This paper discusses the controversy surrounding chronic fatigue syndrome/ME.
This is a clinically diagnosed condition with a variety of symptoms, prominently chronic disabling fatigue which is made worse by physical or mental exertion. Other symptoms include impairment of short term memory and concentration, sleep disturbance, muscle and joint pain and a profound malaise. The illness has a long history, but in spite of this the cause and pathology of the syndrome remain undetermined, generating much debate in scientific literature. There may, in fact, be a variety of different causes for the syndrome which involve a complex interplay of factors.
Researchers are currently examining a range of factors which may play a part in triggering the illness or perpetuating symptoms. These include virus infection, immunological disturbances, changes in muscle energy production, and brain dysfunction (changes in hormones, chemical transmitters and blood flow). Psychological and social factors that may play a part in predisposition to and maintenance of ill health and disability in some cases are also being considered. Uncertainty about the cause of the condition and effective treatment leads to frustration amongst adult and child patients who may suffer debilitating ill health over a number of years. Patient groups are dismayed by misunderstandings and prejudice which they believe surround the illness and have engendered a climate of disbelief which adds to the distress experienced by the sufferer. Difficulties may arise in obtaining appropriate schooling and disability benefits. However, there is now a consensus of opinion that CFS/ME is a definite clinical condition.
Several reports issued since 1994 have raised the profile of the issue and have informed the debate. Differing emphasis on the physiological and psychological aspects of the condition have given rise to controversy. The 1996 report of the Royal Colleges1 laid considerable emphasis on psychological factors which may influence the illness and this gave rise to strong criticisms from some commentators. The Department of Health has set up a working group on CFS/ME which will aim to promote a better understanding of the illness, to produce advice and information on aspects of clinical management, and to set out the evidence on which this information is based.
1 Chronic fatigue syndrome. Report of a joint working group of the Royal Colleges of Physicians, Psychiatrists and General Practitioners October 1996/CR54, Revised 1997"
This is a clinically diagnosed condition with a variety of symptoms, prominently chronic disabling fatigue which is made worse by physical or mental exertion. Other symptoms include impairment of short term memory and concentration, sleep disturbance, muscle and joint pain and a profound malaise. The illness has a long history, but in spite of this the cause and pathology of the syndrome remain undetermined, generating much debate in scientific literature. There may, in fact, be a variety of different causes for the syndrome which involve a complex interplay of factors.
Researchers are currently examining a range of factors which may play a part in triggering the illness or perpetuating symptoms. These include virus infection, immunological disturbances, changes in muscle energy production, and brain dysfunction (changes in hormones, chemical transmitters and blood flow). Psychological and social factors that may play a part in predisposition to and maintenance of ill health and disability in some cases are also being considered. Uncertainty about the cause of the condition and effective treatment leads to frustration amongst adult and child patients who may suffer debilitating ill health over a number of years. Patient groups are dismayed by misunderstandings and prejudice which they believe surround the illness and have engendered a climate of disbelief which adds to the distress experienced by the sufferer. Difficulties may arise in obtaining appropriate schooling and disability benefits. However, there is now a consensus of opinion that CFS/ME is a definite clinical condition.
Several reports issued since 1994 have raised the profile of the issue and have informed the debate. Differing emphasis on the physiological and psychological aspects of the condition have given rise to controversy. The 1996 report of the Royal Colleges1 laid considerable emphasis on psychological factors which may influence the illness and this gave rise to strong criticisms from some commentators. The Department of Health has set up a working group on CFS/ME which will aim to promote a better understanding of the illness, to produce advice and information on aspects of clinical management, and to set out the evidence on which this information is based.
1 Chronic fatigue syndrome. Report of a joint working group of the Royal Colleges of Physicians, Psychiatrists and General Practitioners October 1996/CR54, Revised 1997"
Sir Liam Donaldson was CMO when the report was published.
Dr William Weir and Dr Charles Shepherd were involved as was Wessely.
Dr William Weir and Dr Charles Shepherd were involved as was Wessely.
- Gibson Inquiry 2006 Invest in ME - Gibson inquiry into ME
Dr Ian Gibson MP (Chair) Dr Richard Taylor MP (Vice-Chair) Ms Ann Cryer MP (Secretary) Rt Hon Michael Meacher MP Dr Des Turner MP Mr David Taylor MP Lord Turnberg The Countess of Mar Baroness Cumberlege
- Revised NICE Guideline 2021 Overview | Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management | Guidance | NICE
An infrequently quoted part of this Guideline is in the Overview:
"All problems (adverse events) related to a medicine or medical device used for treatment or in a procedure should be reported to the Medicines and Healthcare products Regulatory Agency using the Yellow Card Scheme.
Local commissioners and providers of healthcare have a responsibility to enable the guideline to be applied when individual professionals and people using services wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with complying with those duties."
When reading these extensive documents together a clear picture emerges and a question arises in my mind:
What in the 'national priorities for funding and developing services' is allowing clear cases of severe ME/CFS to be repeatedly and consistently abused in this way?
ETA:
World Alliance for Patient Safety (who.int)
Sir Liam Donaldson - “To err is human, to cover up is unforgivable, and to fail to learn is inexcusable.”
ETC:
Dr Nigel Speight was also involved in the CMO report 2002.
Last edited: